This user has not added any information to their profile yet.
Bryan Claseman is currently Chairman of the Board at Aurora CTS and Computational Life and a Director of SMMG Medtech and Pulaski Lake Shores Association. He formed Claseman Consulting in 2017 to help early stage and mid-size companies through formation and growth transitions. Prior to forming Claseman Consulting, Mr. Claseman served as Chairman. Board Member, and Interim President and CEO at Biocoat, leading to the successful sale to 1315 Capital, and a Board Member of two non-profit organizations: Pulaski Lake Shores Association and The Path Drama Ministry. He has also held marketing, sales operations, business development, and information technology positions at Spectranetics (now part of Philips), Intact Vascular, Preventice, Cardiovascular Systems, SurModics, Zimmer Spine, Intra-Therapeutics, Boston Scientific, and two divisions of Pfizer (Schneider and American Medical Systems).